Microbot Medical Inc.

MBOT Healthcare Medical Devices

Revenue
+1,047.6%
EPS
+20.0%
Free cash flow
−98.7%

Quarter to June 2026, against a year earlier

1.10 0.03 +2.80%
Market cap
$71.9M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
−19.40
Beneish M
n/a
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Current Ratio
23.33 2.37 2.09 4.26 8.00 18.78 7.45 1.23 20.70 4.23
Net Debt/EBITDA
5.35 0.48 0.66 0.63 1.38 2.74 4.98 0.73 2.06 0.27
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03
ROE
(32.42%) (284.97%) (182.19%) (121.53%) (58.48%) (32.84%) (44.09%) (123.11%) (94.90%) (558.34%)
ROA
(30.01%) (159.40%) (120.24%) (100.12%) (52.56%) (28.92%) (33.54%) (84.86%) (83.50%) (292.99%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(17.18%) (332.74%) (250.88%) (189.03%) (80.01%) (37.95%) (23.13%) (545.86%) (57.25%) (220.85%)
Average Days of Receivables
— — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.29) (0.57) (0.84) (1.60) (1.33) (1.03) (1.50) (1.91) (2.26) (0.85)
Book value per Share
1.69 0.23 0.44 1.00 2.02 3.42 7.39 0.46 4.80 2.30
Free Cash Flow
(13.11) (8.85) (8.57) (11.63) (9.42) (7.34) (6.41) (5.53) (4.91) (0.81)
Other line items

Show all line items

Columns are period end dates